The acquisition of Helvoet Polymer Technologies for EUR 90 million expands medical manufacturing capabilities, strengthens presence in Europe and India, and is expected to be accretive by fiscal 2027. Integration begins immediately, with strong stakeholder support and robust growth prospects.

Based on

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.